Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Posner

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
British Journal of Haematology|October 25, 2011
Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantationHiroto Inaba, Christine M Hartford, Deqing Pei, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2014
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumoursJ Spicer, R Baird, A Suder, et al.
Translational Psychiatry|September 7, 2016
Longitudinal magnetic resonance imaging reveals striatal hypertrophy in a rat model of long-term stimulant treatmentD Biezonski, R Shah, A Krivko, et al.
Journal of Environmental Management|June 28, 2021
Adaptive management as a foundational framework for developing collaborative estuary management programsMatthew J Deitch, Haley N Gancel, Amanda C Croteau, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumoursH-T Arkenau, A Italiano, G Mak, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
British Journal of Haematology|October 25, 2011
Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantationHiroto Inaba, Christine M Hartford, Deqing Pei, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2014
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumoursJ Spicer, R Baird, A Suder, et al.
Translational Psychiatry|September 7, 2016
Longitudinal magnetic resonance imaging reveals striatal hypertrophy in a rat model of long-term stimulant treatmentD Biezonski, R Shah, A Krivko, et al.
Journal of Environmental Management|June 28, 2021
Adaptive management as a foundational framework for developing collaborative estuary management programsMatthew J Deitch, Haley N Gancel, Amanda C Croteau, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumoursH-T Arkenau, A Italiano, G Mak, et al.
Pageof 11